The risk of drug-eluting stent thrombosis with noncardiac surgery

被引：15

作者：

Brilakis E.S. ^{[1
]}

Banerjee S. ^{[1
]}

Berger P.B. ^{[1
]}

机构：

[1] Dallas VA Medical Center (111A), Dallas, TX 75216

来源：

Current Cardiology Reports | 2007年 / 9卷 / 5期

关键词：

Clopidogrel; Antiplatelet Therapy; Bivalirudin; Dual Antiplatelet Therapy; Noncardiac Surgery;

D O I：

10.1007/BF02938368

中图分类号：

学科分类号：

摘要：

Patients in whom any kind of stent, particularly a drug-eluting stent (DES), was recently implanted are at risk for stent thrombosis when they undergo noncardiac surgery, even months or years after their implantation. The risk of DES thrombosis is likely decreased by delaying noncardiac surgery for as long as possible and continuing dual or at least single antiplatelet therapy in the perioperative period. Preoperative identification and close monitoring of patients with DES may allow prevention and prompt detection and treatment of this catastrophic complication. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：406 / 411

页数：5

共 53 条

[1]

Kaluza G.L., Joseph J., Lee J.R., Et al., Catastrophic outcomes of noncardiac surgery soon after coronary stenting, J Am Coll Cardiol, 35, pp. 1288-1294, (2000)

[2]

Wilson S.H., Fasseas P., Orford J.L., Et al., Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting, J Am Coll Cardiol, 42, pp. 234-240, (2003)

[3]

Sharma A.K., Ajani A.E., Hamwi S.M., Et al., Major noncardiac surgery following coronary stenting: When is it safe to operate?, Catheter Cardiovasc Interv, 63, pp. 141-145, (2004)

[4]

Reddy P.R., Vaitkus P.T., Risks of noncardiac surgery after coronary stenting, Am J Cardiol, 95, pp. 755-757, (2005)

[5]

Schouten O., Domburg R.T.V., Bax J.J., Et al., Cardiac outcome after noncardiac surgery in patients with recent coronary stenting, Eur Heart J, 27, SUPPL. 1, (2006)

[6]

Kim H.L., Park K.W., Kwak J.J., Et al., Stent-related cardiac events after non-cardiac surgery: Drug-eluting stent vs. bare metal stent, Int J Cardiol, (2007)

[7]

Iakovou I., Schmidt T., Bonizzoni E., Et al., Incidence, predictors, and outcome of thrombosis after successful implantation of drug-during stents, JAMA, 293, pp. 2126-2130, (2005)

[8]

Daemen J., Wenaweser P., Tsuchida K., Et al., Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study, Lancet, 369, pp. 667-678, (2007)

[9]

Schouten O., van Domburg R.T., Bax J.J., Et al., Noncardiac surgery after coronary stenting: Early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events, J Am Coll Cardiol, 49, pp. 122-124, (2007)

[10]

Marcucci C., Chassot P.G., Gardaz J.P., Et al., Fatal myocardial infarction after lung resection in a patient with prophylactic preoperative coronary stenting, Br J Anaesth, 92, pp. 743-747, (2004)

← 1 2 3 4 5 6 →